Tapewire

NYSE · USD

ABT

ABBOTT LABORATORIES

Export transactions ↓
Tapewire entity
2314
SEC CIK
0000001800
Parsed reports
2,562

Last 12 months

Inside the activity.

6 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202610
Feb 202620
Mar 202606
Apr 202620
May 202610
Jun 202600
Jul 202600
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 07, 2007 Filed Nov 8, 2007 23:00 UTC
Chen Thomas FSenior Vice President
SaleCommon shares without par value 7,400 $54.50 $403,300.00
Disclosure

SEC source: 0001104659-07-081317 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,512

Read SEC document
November 05, 2007 Filed Nov 7, 2007 21:30 UTC
Chen Thomas FSenior Vice President
SaleCommon shares without par value 2,600 $54.50 $141,700.00
Disclosure

SEC source: 0001104659-07-080724 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,912

Read SEC document
September 30, 2007 Filed Oct 3, 2007 00:06 UTC GrantStock equivalent units · Derivative 503 $53.62 Strike: $0.00 $26,970.86
Disclosure

SEC source: 0001104659-07-072701 · a4.xml · derivative · entry 1

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,240

Underlying: common shares · 503 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2007 Filed Oct 3, 2007 00:09 UTC GrantStock equivalent units · Derivative 475 $53.62 Strike: $0.00 $25,469.50
Disclosure

SEC source: 0001104659-07-072702 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 795

Underlying: common shares · 475 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2007 Filed Oct 3, 2007 00:11 UTC GrantStock equivalent units · Derivative 475 $53.62 Strike: $0.00 $25,469.50
Disclosure

SEC source: 0001104659-07-072703 · a4.xml · derivative · entry 1

TILTON GLENN F · CIK 0001194624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 795

Underlying: common shares · 475 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2007 Filed Oct 3, 2007 00:13 UTC GrantStock equivalent units · Derivative 447 $53.62 Strike: $0.00 $23,968.14
Disclosure

SEC source: 0001104659-07-072705 · a4.xml · derivative · entry 1

DALEY WILLIAM M · CIK 0001183865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,254

Underlying: common shares · 447 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2007 Filed Oct 3, 2007 00:19 UTC GrantStock equivalent units · Derivative 279 $53.62 Strike: $0.00 $14,959.98
Disclosure

SEC source: 0001104659-07-072706 · a4.xml · derivative · entry 1

POWELL BOONE JR · CIK 0001232973 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,280

Underlying: common shares · 279 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2007 Filed Oct 3, 2007 00:21 UTC GrantStock equivalent units · Derivative 531 $53.62 Strike: $0.00 $28,472.22
Disclosure

SEC source: 0001104659-07-072707 · a4.xml · derivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,040

Underlying: common shares · 531 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2007 Filed Oct 3, 2007 00:24 UTC
GONZALEZ RICHARD ADirector · President and COO
Tax withholdingCommon shares without par value 6,102 $53.62 $327,189.24
Disclosure

SEC source: 0001104659-07-072708 · a4.xml · nonDerivative · entry 1

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,108

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 200 $53.81 $10,762.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 16

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299,210

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 4,278 $53.80 $230,156.40
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 15

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299,410

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 7,600 $53.79 $408,804.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 14

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,688

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 18,100 $53.78 $973,418.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 13

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,288

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 9,100 $53.77 $489,307.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 12

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329,388

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 5,100 $53.76 $274,176.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 11

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,488

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 12,400 $53.75 $666,500.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 10

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,588

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 11,400 $53.74 $612,636.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 9

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,988

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 18,400 $53.73 $988,632.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 8

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 367,388

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 15,100 $53.72 $811,172.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 7

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 385,788

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 8,300 $53.71 $445,793.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 6

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,888

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 12,200 $53.70 $655,140.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 5

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,188

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 5,700 $53.69 $306,033.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 4

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,388

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 4,500 $53.68 $241,560.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 3

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427,088

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 10,100 $53.67 $542,067.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 2

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431,588

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:18 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 12,100 $53.66 $649,286.00
Disclosure

SEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 1

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 441,688

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
GrantOption (right to buy) · Derivative 1,864 $0.00 Strike: $53.60 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 18

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,864

Underlying: common shares · 1,864 shares

Expires 2009-02-11

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
GrantOption (right to buy) · Derivative 1,878 $0.00 Strike: $53.60 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 17

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,878

Underlying: common shares · 1,878 shares

Expires 2014-02-19

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
GrantOption (right to buy) · Derivative 1,890 $0.00 Strike: $53.60 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 16

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,890

Underlying: common shares · 1,890 shares

Expires 2013-02-13

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
GrantOption (right to buy) · Derivative 344,826 $0.00 Strike: $53.60 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 15

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,826

Underlying: common shares · 344,826 shares

Expires 2014-02-19

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
GrantOption (right to buy) · Derivative 92,521 $0.00 Strike: $53.60 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 14

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,521

Underlying: common shares · 92,521 shares

Expires 2008-09-14

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
GrantOption (right to buy) · Derivative 314,796 $0.00 Strike: $53.60 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 13

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,796

Underlying: common shares · 314,796 shares

Expires 2009-02-11

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionOption (right to buy) · Derivative 3,050 $0.00 Strike: $33.23 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 12

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 3,050 shares

Expires 2013-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionOption (right to buy) · Derivative 404,340 $0.00 Strike: $41.03 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 11

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 404,340 shares

Expires 2014-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionOption (right to buy) · Derivative 108,502 $0.00 Strike: $40.56 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 10

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1

Underlying: common shares · 108,502 shares

Expires 2008-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionOption (right to buy) · Derivative 362,291 $0.00 Strike: $42.50 $0.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · derivative · entry 9

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,128

Underlying: common shares · 362,291 shares

Expires 2009-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Tax withholdingCommon shares without par value 757,775 $53.60 $40,616,740.00
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 5

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,055,114

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionCommon shares without par value 3,050 $33.23 $101,355.77
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 4

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,812,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionCommon shares without par value 404,340 $41.03 $16,590,757.58
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 3

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,809,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionCommon shares without par value 108,502 $40.56 $4,401,036.42
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 2

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,405,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:20 UTC
WHITE MILES DDirector · Chairman and CEO
Exercise / conversionCommon shares without par value 362,291 $42.50 $15,396,570.46
Disclosure

SEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 1

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,296,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
Exercise / conversionOption (right to buy) · Derivative 69,705 $0.00 Strike: $33.23 $0.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · derivative · entry 30

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 69,705 shares

Expires 2013-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
Exercise / conversionOption (right to buy) · Derivative 179,473 $0.00 Strike: $41.03 $0.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · derivative · entry 29

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,454

Underlying: common shares · 179,473 shares

Expires 2014-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 15,800 $53.65 $847,670.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 28

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 453,788

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 9,700 $53.64 $520,308.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 27

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 469,588

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 8,000 $53.63 $429,040.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 26

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 479,288

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 2,600 $53.62 $139,412.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 25

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 487,288

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 3,400 $53.61 $182,274.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 24

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 489,888

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 4,100 $53.60 $219,760.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 23

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 493,288

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 200 $53.59 $10,718.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 22

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 497,388

Read SEC document
September 19, 2007 Filed Sep 22, 2007 00:14 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 700 $53.58 $37,506.00
Disclosure

SEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 21

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 497,588

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.